User profiles for Ulrich Pison

Ulrich Pison

Charité-Universitätsmedizin Berlin
Verified email at charite.de
Cited by 7520

[HTML][HTML] Inhaled nitric oxide for the adult respiratory distress syndrome

…, KJ Falke, F Lopez, K Slama, U Pison… - … England Journal of …, 1993 - Mass Medical Soc
Background The adult respiratory distress syndrome is characterized by pulmonary hypertension
and right-to-left shunting of venous blood. We investigated whether inhaling nitric oxide …

Nanomedicine for respiratory diseases

U Pison, T Welte, M Giersig, DA Groneberg - European journal of …, 2006 - Elsevier
Nanotechnology provides new materials in the nanometer range with many potential
applications in clinical medicine and research. Due to their unique size-dependent properties …

One-pot synthesis of PEGylated ultrasmall iron-oxide nanoparticles and their in vivo evaluation as magnetic resonance imaging contrast agents

JF Lutz, S Stiller, A Hoth, L Kaufner, U Pison… - …, 2006 - ACS Publications
A well-defined copolymer poly(oligo(ethylene glycol) methacrylate-co-methacrylic acid) P(OEGMA-co-MAA)
was studied as a novel water-soluble biocompatible coating for …

Maghemite Nanoparticles Protectively Coated with Poly(ethylene imine) and Poly(ethylene oxide)-block-poly(glutamic acid)

AF Thünemann, D Schütt, L Kaufner, U Pison… - Langmuir, 2006 - ACS Publications
Superparamagnetic iron oxide particles (SPIO) of maghemite were prepared in aqueous
solution and subsequently stabilized with polymers in two layer-by-layer deposition steps. The …

Pulmonary surfactant: functions, abnormalities and therapeutic options

I Frerking, A Günther, W Seeger, U Pison - Intensive care medicine, 2001 - Springer
The first successful clinical pilot studies of surfactant replacement were published about 20
years ago as a logical extension of experimental studies showing beneficial effects in pre-…

Nanoparticle-based diagnosis and therapy

…, M Giersig, T Welte, U Pison - Current drug targets, 2006 - ingentaconnect.com
Nanoparticles are at the leading edge of the rapidly developing field of material science in
nanotechnology with many potential applications in clinical medicine and research. Due to …

Surfactant Abnormalities in Patients with Respiratory Failure after Multiple Trauma1-3

U Pison, W Seeger, R Buchhorn, T Joka… - Am Rev Respir …, 1989 - atsjournals.org
We present a prospective study, designed to evaluate surfactant abnormalities In severely
injUred patients during the course of post-traumatic pulmonary dysfunction. Serially obtained …

Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange

U Pison, FA Lopez, CF Heidelmeyer… - Journal of Applied …, 1993 - journals.physiology.org
Nitric oxide (NO) is an endogenous endothelium-derived relaxing factor that participates in
the regulation of vascular tone. We studied the effects of inhaled NO gas on transient hypoxic …

DCL-HB for trauma patients with severe hemorrhagic shock: the European" on-scene" multicenter study

…, O Ahlers, S Veit, B Riou, M Saunders, U Pison… - Intensive care …, 2003 - Springer
Objective A major cause of death in patients with severe hemorrhagic shock following
trauma is the subsequent occurrence of multiple organ failure due to tissue hypoxia. Early …

Specific binding of surfactant apoprotein SP-A to rat alveolar macrophages

U Pison, JR Wright, S Hawgood - American Journal of …, 1992 - journals.physiology.org
Surfactant protein A (SP-A) influences the function of alveolar macrophages in vitro. In this
study the characteristics of the binding of 125I-labeled SP-A to rat alveolar macrophages has …